Filing Flows

Filing Flows › Sanara MedTech (SMTI) › Q1 2026 › vs Q4 2025

Sanara MedTech (SMTI) Q1 2026 vs Q4 2025 (quarter over quarter)

Sanara MedTech's revenue rose $253K (+0.9%) from $27.5M in Q4 2025 to $27.8M in Q1 2026. The biggest changes: Soft Tissue Repair Products +$213K (+0.9%); Bone Fusion Products +$39K (+1%). Gross margin 93.1% against 93.2% (-0.1 pts).

Sanara MedTech, Q1 2026: revenue $27.8M (+19% year over year), operating margin 9.5%, net earnings $459K, operating cash flow −$2.5M. The chart draws each line against Q4 2025, the increases inside each band.

Sanara MedTech: what changed, Q1 2026 vs Q4 2025Sanara MedTech: what changed, Q1 2026 vs Q4 2025Operating cash sources$8.2MWorking capital & other$8.2MCash used in operations$6.4MPre-tax earnings$2.1MNet earnings$2.1MOther operating costs−$1.9MOperating profit$1.6MOperating expenses−$1.4MResearch & development−$1.3MOther expense, net−$473K

Margins

Q1 2026Q4 2025Change
Gross margin93.1%93.2%-0.1 pts
Operating margin9.5%3.8%+5.7 pts
Net margin1.6%-5.8%+7.5 pts

Every line

LineQ1 2026Q4 2025Change%
Soft Tissue Repair Products$24.9M$24.7M$213K+0.9%
Bone Fusion Products$2.9M$2.8M$39K+1%
Revenue$27.8M$27.5M$253K+0.9%
Gross profit$25.9M$25.7M$204K+0.8%
Cost of revenue$1.9M$1.9M$49K+3%
Operating profit$2.6M$1.1M$1.6M+152%
Operating expenses$23.2M$24.6M−$1.4M-6%
Pre-tax earnings$459K−$1.6M$2.1M—
Other expense, net$2.2M$2.7M−$473K-18%
Research & development$760K$2.0M−$1.3M-63%
Other operating costs$587K$2.5M−$1.9M-77%
Net earnings$459K−$1.6M$2.1M—
Operating cash sources$4.5M−$3.7M$8.2M—
Depreciation & amortization$587K$668K−$81K-12%
Share-based compensation$1.0M$1.2M−$154K-13%
Cash used in operations$2.5M−$3.9M$6.4M—
Working capital & other$4.5M−$3.7M$8.2M—

Questions

How much did Sanara MedTech's revenue grow quarter over quarter in Q1 2026?

Sanara MedTech's revenue rose $253K (+0.9%) from $27.5M in Q4 2025 to $27.8M in Q1 2026.

What drove Sanara MedTech's revenue change in Q1 2026?

Soft Tissue Repair Products +$213K (+0.9%); Bone Fusion Products +$39K (+1%).

Q1 2026 results → · Compare in the interactive Sankey →